Literature DB >> 17597229

Macrophage tolerance induced by stimulation with Toll-like receptor 7/8 ligands.

Kunihisa Tsukada1, Takatoshi Kitazawa, Atsuhito Fukushima, Shu Okugawa, Shintaro Yanagimoto, Keita Tatsuno, Kazuhiko Koike, Hiroyuki Nagase, Koichi Hirai, Yasuo Ota.   

Abstract

The engagement of Toll-like receptors (TLRs) results in resistance to subsequent challenge with respective ligands in macrophages. Studies have shown that stimulation by ligands for TLR2, TLR4, TLR5 and TLR9 induces this state of hypo-responsiveness (homo-tolerance) towards subsequent stimulation with the same ligands. However, whether homo-tolerance is induced by the ligands of TLR7/8 has not been previously determined. We found that ligands for TLR7/8, namely ss-RNA from HIV and an imidazoquinoline compound, R848, induced macrophage tolerance, as judged by the production of the chemokine MIP-1beta. IRAK-1 phosphorylation was also inhibited in the tolerant cells after subsequent stimulation with R848, although no significant differences were observed in the protein levels of TLR7 between tolerant and non-tolerant cells. These results indicate that macrophage tolerance induced by TLR7/8 ligands is regulated at least at the level of IRAK-1 activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597229     DOI: 10.1016/j.imlet.2007.05.001

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7.

Authors:  Tomoko Hayashi; Christine S Gray; Michael Chan; Rommel I Tawatao; Lisa Ronacher; Maureen A McGargill; Sandip K Datta; Dennis A Carson; Maripat Corr
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

2.  Antigen receptor signals rescue B cells from TLR tolerance.

Authors:  Jayakumar S Poovassery; Tony J Vanden Bush; Gail A Bishop
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

3.  Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model.

Authors:  Veronika Caisová; Andra Vieru; Zuzana Kumžáková; Simona Glaserová; Hana Husníková; Nikol Vácová; Gabriela Krejčová; Lucie Paďouková; Ivana Jochmanová; Katherine I Wolf; Jindřich Chmelař; Jan Kopecký; Jan Ženka
Journal:  BMC Cancer       Date:  2016-12-07       Impact factor: 4.430

Review 4.  The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome.

Authors:  Carlene Petes; Natalya Odoardi; Katrina Gee
Journal:  Front Immunol       Date:  2017-09-04       Impact factor: 7.561

5.  Macrophage MMP10 Regulates TLR7-Mediated Tolerance.

Authors:  Maryam G Rohani; Elizabeth Dimitrova; Andrew Beppu; Ying Wang; Caroline A Jefferies; William C Parks
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

6.  Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors.

Authors:  Daniela C Ifrim; Jessica Quintin; Leo A B Joosten; Cor Jacobs; Trees Jansen; Liesbeth Jacobs; Neil A R Gow; David L Williams; Jos W M van der Meer; Mihai G Netea
Journal:  Clin Vaccine Immunol       Date:  2014-02-12

7.  Immunotherapy of Dual-Function Vector with Both Immunostimulatory and B-Cell Lymphoma 2 (Bcl-2)-Silencing Effects on Gastric Carcinoma.

Authors:  Lanying Ma; Mei Han; Zumureti Keyoumu; Hua Wang; Saifuding Keyoumu
Journal:  Med Sci Monit       Date:  2017-04-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.